Literature DB >> 54896

Studies on cystic fibrosis using isoelectric focusing. II. Demonstration of deficient proteolytic cleavage of alpha2-macroglobulin in cystic fibrosis plasma.

G B Wilson, H H Fudenberg.   

Abstract

A protein with an isoelectric point (pI) of 5.48 was found to be deficient in plasma from most cystic fibrosis (CF) homozygotes and obligate heterozygote carriers of CF as compared with normal control plasma. Purification of the protein with a pI of 5.48 from normal plasma was performed using ammonium sulfate precipitation, DEAE-cellulose and CM-cellulose chromatography, Sephadex G-200- gel filtration, starch block electrophoresis, and Sepharose 4B gel filtration. The purified protein migrated as a single band on polyacrylamide gel electrophoresis, and displayed a single arc on immunoelectrophoresis against polyvalent antiserum to whole human serum. Results from various techniques used in its characterization indicate that this protein is a fragment of alpha2-macroglobulin (alpha2M) which is derived from alpha2M by proteolytic cleavage of intact alpha2M subunits. Quantitation of alpha2M levels in plasma indicated no significant differences between levels of alpha2M in CF homozygote, obligate heterozygote carrier, or normal control plasma samples. Quantitation of arginine esterase activity in plasma treated with cloroform and ellagic acid indicated that both the total arginine esterase activity and that fraction of arginine esterase activity inhibited by soybean trypsin inhibitor (SBTI) were decreased in most CF homozygote and obligate heterozygote plasma samples relative to normal control values. The results of this study indicate that plasma samples from CF homozygotes and obligate heterozygote carriers for CF show deficient proteolytic cleavage of alpha2M as compared with normal control plasma, and suggest that a structural abnormality in alpha2M or a deficiency in plasma proteolytic activity may be responsible for this deficiency in proteolysis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 54896     DOI: 10.1203/00006450-197602000-00003

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  4 in total

1.  Distribution of complement C3 variants in individuals with cystic fibrosis.

Authors:  S Lederberg; D Sackett
Journal:  Am J Hum Genet       Date:  1976-11       Impact factor: 11.025

2.  The electrophoretically 'slow' and 'fast' forms of the alpha 2-macroglobulin molecule.

Authors:  A J Barrett; M A Brown; C A Sayers
Journal:  Biochem J       Date:  1979-08-01       Impact factor: 3.857

3.  Cystic fibrosis ciliary dyskinesia substances and pulmonary disease. Effects of ciliary dyskinesia substances on neutrophil movement in vitro.

Authors:  G B Wilson; H H Fudenberg; M T Parise; E Floyd
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

4.  Modifications of plasma fibronectin in cystic fibrosis patients.

Authors:  L Stanislawski; M Sorin
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.